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ABSTRACT
Objectives: (1) To assess endorsement of trial
registration in author instructions of urology-related
journals and (2) to assess whether randomised
controlled trials (RCTs) in the ﬁeld of urology were
effectively registered.
Design: Cross-sectional study of author instructions
and published trials.
Setting: Journals publishing in the ﬁeld of urology.
Participants: First, the authors analysed author
instructions of 55 urology-related journals indexed in
‘Journal Citation Reports 2009’ (12/2010). The authors
divided these journals in two groups: those requiring
and those not mentioning trial registration as
a precondition for publication. Second, the authors
chose the ﬁve journals with the highest impact factor
(IF) from each group.
Intervention: MEDLINE search to identify RCTs
published in these 10 journals in 2009 (01/2011);
search of the clinical trials meta-search interface of
WHO (International Clinical Trials Registry Platform)
for RCTs that lacked information about registration
(01e03/2011). Two authors independently assessed
the information.
Outcome measures: Proportion of journals providing
advice about trial registration and proportion of trials
registered.
Results: Of 55 journals analysed, 26 (47.3%) provided
some editorial advice about trial registration. Journals
with higher IFs were more likely to mention trial
registration explicitly (p¼0.015). Of 106 RCTs
published in 2009, 63 were registered (59.4%) with
a tendency to an increase after 2005 (83.3%,
p¼0.035). 71.4% (30/42) of the RCTs that were
published in journals mentioning and requiring
registration, and 51.6% (33/64) of the RCTs that were
published in journals that did not mention trial
registration explicitly were registered. This difference
was statistically signiﬁcant (p¼0.04).
Conclusions: The existence of a statement about trial
registration in author instructions resulted in a higher
proportion of registered RCTs in those journals.
Journals with higher IFs were more likely to mention
trial registration.
INTRODUCTION
Transparency is essential for the efﬁcient
transfer of scientiﬁc knowledge gained from
research into practice. Nevertheless, recent
studies have shown that transparency is
impaired by non-publication or inappro-
priate publication of trial results. A major
reason is selective publication, either of
whole trials or of certain outcomes, which is
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ARTICLE SUMMARY
Article focus
- Trial registration can increase scientiﬁc trans-
parency, but its implementation in specialty ﬁelds
such as urology is unclear.
- To assess the endorsement of trial registration in
the author instructions of urology-related jour-
nals.
- To assess whether randomised controlled trials
in the ﬁeld were effectively registered.
Key messages
- A statement of trial registration in author
instructions resulted in a higher proportion of
registered randomised controlled trials.
- Journals with high impact factors were more
likely to mention trial registration.
- We suggest, though, that ensuring trial registra-
tion is not the responsibility only of the editors.
Medical scientists should realise that trial
registration is necessary to contribute to trans-
parency in research.
Strength and limitations of this study
- Two authors independently assessed information
regarding editorial advice about trial registration
and identiﬁed the randomised controlled trials.
- Potential bias occurred if registered randomised
controlled trials were reported without giving
a registration number and we could not identify
them in the meta-search interface of WHO
(International Clinical Trials Registry Platform).
- Results might not be representative of the uro-
nephrological ﬁeld as a whole and reported
ﬁgures may overestimate compliance with trial
registration.
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Open Access Researchreferred to as publication bias or outcome reporting
bias, respectively.
1 2 Other reasons that hamper the
generation of valid results from trials are limitations in
trial methodology and reporting of trial results. A
recently published Cochrane Review evaluated studies
that compared the content of protocols and register
entries with published reports of randomised controlled
trials (RCTs). The authors found that it is common
practice to add, omit or change outcome parameters in
the reporting of study results, which leads to discrep-
ancies between study protocols or register entries and
reported results.
3 As very recently shown by a retrospec-
tive analysis of data entries in http://clinicaltrials.gov on
randomised trials on diseases in the digestive system,
information available in trial registers was partly inade-
quate, 30% of trials were registered incorrectly after
their completion date and registered information and
trial publications showed discrepancies.
4
The complete registration of all trials has the potential
to increase transparency in scientiﬁc research. Members
of the International Committee of Medical Journal
Editors (ICMJE) promoted trial registration in 2004 by
publishing a statement on it.
5 The ICMJE deﬁned 1 July
2005 as a key date requiring prospective trial registration
(registration before recruitment started) for trials
started after this date. For trials that began enrolment
prior to this date, the ICMJE member journals allowed
for retrospective registration by 13 September 2005.
5
WHO supported this joint effort of journals by founding
the International Clinical Trials Registry Platform
(ICTRP), which brings together data sets provided by
different primary registers worldwide. As of 1 July 2007,
also the Surgery Journal Editors Group member journals
required prospective registration of all clinical trials.
From this date on, the Surgery Journal Editors Group
member journals planned to consider trials only if they
are registered before enrolment of the ﬁrst study
subject.
6 In 2007, several editors from major medical
journals stated that ‘three years ago, trial registration was
the exception and now it is the rule’,
7 suggesting that
trial registration nowadays is in fact an integral part of
clinical research.
It is unclear, however, to what extent trial registration
is implemented in specialty ﬁelds such as urology. To
address this question, we aimed to assess the endorse-
ment of trial registration in journal author instructions
in relevant urology journals. Second, we sought to
determine whether a statement of trial registration in
author instructions resulted in a higher proportion of
registered RCTs published in 2009.
METHODS
We included in this study all journals that were indexed
in the subject categories ‘Urology & Nephrology’ or
‘Andrology’ in the ‘Journal Citation Reports 2009’.
8 We
examined author instructions available via journal
websites (12/2010) and did not impose any language
restriction. Two authors (FK and HRG) independently
read each document and used relevant key words in
electronic full-text searches to extract information about
whether the journal (1) publishes original investigations,
(2) gives editorial advice about trial registration and (3)
endorses the ‘Uniform Requirements for Manuscripts
Submitted to Biomedical Journals’ (URM) recommen-
dation of the ICMJE.
9 Disagreements were resolved by
rechecking the respective websites and, if necessary, by
discussion with a third author (JJM).
Journals reporting reviews or commissioned articles
only were excluded. We noted if journals recommended
or required trial registration as a precondition for
publication. In addition, we assessed the context in
which the URM appeared in a journal. If the journal
guidelines mentioned the URM only in the context of
‘conﬂicts of interest’ or ‘style of references’, we classiﬁed
the URM for this journal as ‘not relevant’ for advice
about trial registration. If trial registration was either
required or recommended or if the guidelines
mentioned the URM in the context of trial registration,
we classiﬁed the journal as ‘direct reference to trial
registration’. If the guidelines mentioned the URM in
the context of general manuscript preparation without
other editorial advice on trial registration, we classiﬁed it
as ‘indirect reference to trial registration’.
In a second step, we assessed whether a statement of
trial registration in author instructions of uro-
nephrology journals resulted in a higher proportion of
registered RCTs. On the basis of our evaluation, we
selected the 10 journals (ﬁve journals that mentioned
and required trial registration and ﬁve journals that did
not mention trial registration directly in their author
instructions) with the highest impact factor (IF) in their
respective group (table 1). We have chosen these jour-
nals to obtain a reasonably sized, representative sample
of trials published in the major uro-nephrological
Table 1 Groups of journals giving some or no advice on trial registration in their author instructions
Trial registration mentioned and required IF Trial registration not mentioned directly IF
Journal of the American Society of Nephrology 7.689 Journal of Urology 4.016
European Urology 7.667 American Journal of Nephrology 3.481
Kidney International 6.193 Nephrology Dialysis Transplantation 3.306
American Journal of Kidney Diseases 5.152 Prostate 3.081
Clinical Journal of the American Society of Nephrology 4.844 British Journal of Urology International 2.865
IF, impact factor.
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Trial registration in urologyjournals supporting or not supporting prospective trial
registration. We then searched Ovid MEDLINE (01/
2011, box 1) to identify RCTs that were published in
2009 in these journals using the ‘Cochrane Highly
Sensitive Search Strategy’.
10
One author (FK) screened the titles and abstracts of all
retrieved references and excluded only citations that
were clearly irrelevant or duplicates. Two authors (FK
and HRG) then independently from each other identi-
ﬁed RCTs and excluded non-randomised trials and
discussed discrepancies with a third party (JJM). Trials
recruiting patients prior to 2004 were excluded because
registration was not strongly promoted at that time. The
2004 ICMJE statement promoting trial registration had
deﬁned 1 July 2005 as a key date for prospective trial
registration (registration before recruitment started). To
investigate possible changes in registration practice, we
subdivided trials into two groups according to the start of
patient recruitment: 2004e2005 and $2006. The ICMJE
accepted retrospective registration (registration when
recruitment was already happening) of trials that began
before 1 July 2005.
9 For this reason, we did not investi-
gate if trial registration was done pro- or retrospectively.
We searched the ICTRP (01e03/2011) for every
report of an RCT without information about trial
registration by using relevant key words based on the
Patients, Intervention, Control, Outcome, Time
scheme.
11 The ICTRP is periodically updated and
contains data sets of registers from Australia, New
Zealand, China, India, Republic of Korea, Germany,
Iran, Japan, Africa, Sri Lanka and the Netherlands as
well as from ‘ClinicalTrials.gov’ and the ‘International
Standard Randomised Controlled Trial Number
Register’.
The inﬂuence of the IF on trial registration endorse-
ment was evaluated using logistic regression. Statistical
tests were two sided, and p<0.05 was considered signif-
icant.
RESULTS
We identiﬁed 69 journals in the subject categories
‘Urology & Nephrology’ (n¼63) and ‘Andrology’ (n¼6).
Fourteen journals were excluded for various reasons
(ﬁgure 1); 55 journals were evaluated. The IFs ranged
from 0.054 to 7.689.
Twenty journals (36.4%) mentioned trial registration
as a direct reference in their author instructions, two of
these (10%, IF<2.0) recommended trial registration and
18 journals (90%, IF>0.01) required trial registration as
a precondition for publication (table 2).
A total of 32 journals (58.2%) mentioned the URM of
the ICMJE. However, 18 journals (32.7%) mentioned the
URM only in the context of conﬂict of interest (n¼8) or
style of references (n¼10). Fourteen journals (25.5%)
mentioned the URM in the context of trial registration
(n¼2) or general manuscript preparation (n¼12). All
journals that mentioned the URM in the context of trial
registration also required or recommended trial regis-
tration. This was additionally the case for six of the 12
journals mentioning the URM in the context of general
manuscript preparation. Thus, six journals (10.9%) gave
an indirect reference to trial registration by mentioning
the URM exclusively in the context of general manu-
script preparation (table 2).
Twenty-six journals (47.3%) made some kind of
reference to trial registration, either by directly or indi-
rectly referring to the URM in their author instructions
Box 1 Search strategy for identifying randomised
controlled trials in journals relevant to urology
Database: Ovid MEDLINE(R) In-Process & Other Non-
Indexed Citations, Ovid MEDLINE(R) Daily and Ovid
MEDLINE(R) 1946 to Present.
Searched: 17.01.2011.
Responsible searcher: Kunath
1. european urology.jn.
2. kidney international.jn.
3. american journal of kidney diseases.jn.
4. clinical journal of the american society of nephrology
cjasn.jn.
5. journal of the american society of nephrology.jn.
6. bju international.jn.
7. journal of urology.jn.
8. american journal of nephrology.jn.
9. nephrology dialysis transplantation.jn.
10. prostate.jn.
11. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10
12. randomized controlled trial.pt.
13. controlled clinical trial.pt.
14. randomized.ab.
15. placebo.ab.
16. clinical trials as topic.sh.
17. randomly.ab.
18. Trial.ti.
19. 12 or 13 or 14 or 15 or 16 or 17 or 18
20. exp animals/ not humans.sh.
21. 19 not 20
22. 11 and 21
23. limit 22 to yr¼"2009" Figure 1 Selection of relevant journals from the ‘Journal
Citation Reports 2009’.
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Trial registration in urology(table 2). Six of seven journals (85.7%) with IFs above
4.01 included such indirect editorial advice. The likeli-
hood of a direct reference to trial registration was
signiﬁcantly higher with increasing IF (p¼0.015).
Our search strategy for the evaluation of the registra-
tion practice for RCTs published in 2009 retrieved 429
citations; our evaluation included 106 RCTs (ﬁgure 2).
Fifty-two RCTs (49%) had started patient recruitment in
2004e2005, 36 (34%) during or after 2006 and in 18
RCTs (17%), the start of patient recruitment was not
speciﬁed (table 3). These 18 trials were cross-over trials,
RCTs with an interventional duration of <12 weeks
(n¼14, 77.8%) or RCTs with a follow-up of <2 years
(n¼4, 22.2%).
In total, 63 of the 106 RCTs (59.4%) were registered,
33 with recruitment from 2004 to 2005 (33/52, 63.5%)
and 30 with recruitment in 2006 or later (30/36, 83.3%)
(table 3). The difference between these two proportions
was statistically signiﬁcant (RR 0.76, 95% CI 0.59e0.98,
p¼0.035). Of the 63 registered RCTs, 48 speciﬁed the
registration number (76.2%). Following the search of
the ICTRP, 15 additional trials (23.8%) were classiﬁed as
‘registered’, although no reference to their registration
was given in their publication. We found no differences
in reporting of registration between RCTs with patient
recruitment in 2004e2005 and during or after 2006
(table 3, registration mentioned in article: 75.8% vs
76.7%; no registration mentioned in article but regis-
tered in the ICTRP: 24.2% vs 23.3%, respectively). Forty-
three RCTs (40.6%) did not report registration and
could not be identiﬁed in the ICTRP (table 3).
Of the 42 RCTs that were published in journals that
mentioned and required trial registration as a precondi-
tion for publication, 71.4% (30/42) were registered and
28.6% (12/42) were not registered (table 4). In contrast
to this, of the 64 RCTs that were published in journals
that did not mention trial registration directly in their
author instructions, only 51.6% (33/64) were registered
and 48.4% (31/64) were not registered (table 4). The
proportion of reports of registered trials was signiﬁcantly
higher in journals that mentioned and required trial
registration as a precondition for publication than those
Table 2 Endorsement of trial registration in author instructions
All journals IF 0.01e2.0 IF 2.01e4.0 IF>4.01
n[55 (100%) n[30 (100%) n[18 (100%) n[7 (100%)
Direct reference to trial registration 20 (36.4) 8 (26.7) 7 (38.9) 5 (71.43)
Required 18 (90) 6 (75) 7 (100) 5 (100)
Recommended 2 (10) 2 (25) ee
Indirect reference to trial registration 6 (10.9) 3 (10) 2 (11.1) 1 (14.29)
Any advice about trial registration 26 (47.3) 11 (36.7) 9 (50) 6 (85.72)
IF, impact factor.
Figure 2 Selection of
randomised controlled trials
(RCTs).
4 Kunath F, Grobe HR, Keck B, et al. BMJ Open 2011;1:e000430. doi:10.1136/bmjopen-2011-000430
Trial registration in urologythat did not mention trial registration directly in their
author instructions (p¼0.04).
DISCUSSION
We assessed the endorsement of trial registration in
author instructions of urology-related journals. Only
36.4% of uro-nephrology journals gave direct editorial
advice about trial registration. Of interest, a higher IF
was signiﬁcantly associated with the likelihood of giving
direct advice about trial registration. More than half of
all RCTs published in 2009 and the vast majority (83%)
of trials with patient recruitment during or after 2006
were registered (table 3). Three quarters of the RCTs
that were published in journals mentioning and
requiring trial registration as a precondition for publi-
cation were registered (table 4).
Although the ICMJE, WHO and the World Medical
Association support trial registration,
9 12 13 the advice
given in the author instructions of uro-nephrology
journals does not sufﬁciently reﬂect this recommenda-
tion. This situation, however, is not as comparatively
negative as it might seem at ﬁrst. Meerpohl et al
14 eval-
uated the editorial policies of paediatric journals and
demonstrated that only one-quarter of all selected jour-
nals required or recommended trial registration in their
author instructions. Another study compared Italian
journals (n¼76) indexed in Medline and randomly
chosen journals from the UK (n¼76) with regard to
editorial advice on trial registration. Surprisingly, none
of the Italian journals required trial registration, while
28% of the UK journals mentioned registration.
15
The data presented here show that the reporting of
registration can still be improved, and we suggest that
this problem is general in the scientiﬁc literature. Reveiz
et al evaluated the key methodological items of RCTs
published in 55 of the highest-ranking journals. Only
36% of 148 included RCTs reported that the study was
registered in any trial register.
16 Awareness of trial
registration was raised in the scientiﬁc community in
2005. This awareness translated into a statistically
signiﬁcant increase in trial registrations for RCTs with
patient recruitment after 2005 in urology and better
registration of trials in other medical specialties. Hamm
et al
17 found that only one-quarter of all paediatric RCTs
published in 2007 were in fact registered. Similarly,
a study of 323 RCTs from medical departments
published in journals with high IFs identiﬁed only 46%
of those as adequately registered trials.
18 However,
these studies did not differentiate between trial regis-
tration for RCTs with patient recruitment before, during
or after 2005.
Potential bias in our data may have emerged when
registered RCTs could not be identiﬁed in the ICTRP,
and the start of patient recruitment was not mentioned
in the manuscript. Because this potential limitation
hinders the detection of studies in registries, it is also
a handicap for transparency in research. If we assumed
that patient recruitment in trials not reporting a regis-
tration number or not specifying their conduct
happened in or after 2006, the proportion of registered
trials would decrease. In addition, the RCTs analysed
were taken from the ﬁve uro-nephrological journals with
the highest IF in their respective categories. It may well
be that RCTs published in these journals with higher
IFs are more likely to be registered. Our results
might, therefore, overestimate compliance with trial
registration and be, accordingly, not representative of
the uro-nephrological ﬁeld as a whole.
In an ideal world, knowledge translation would be
supported by the prospective registration of trials as well
Table 3 Registration of RCTs
Start of patient recruitment
All 2004e2005 ‡2006 Not speciﬁed
n[106 (100%) n[52 (100%) n[36 (100%) n[18 (100%)
Registered RCTs 63 (59.4) 33 (63.5) 30 (83.3) 0
Registration mentioned in article 48 (76.2) 25 (75.8) 23 (76.7) 0
No registration mentioned in article;
registered in the ICTRP
15 (23.8) 8 (24.2) 7 (23.3) 0
Not registered in the ICTRP; no registration
mentioned in article
43 (40.6) 19 (36.5) 6 (16.7) 18 (100)
ICTRP, International Clinical Trials Registry Platform; RCTs, randomised controlled trials.
Table 4 Registration of RCTs published in journals
mentioning and requiring or not mentioning trial registration
in their author instructions
RCTs (n[106)
Registered
RCTs (n[63)
Non-registered
RCTs (n[43)
Trial registration mentioned and required
All (n¼42, 100%) 30 (71.4) 12 (28.6)
2004e2005 18 (60) 2 (16.7)
$2006 12 (40) 2 (16.7)
Not speciﬁed 0 8 (66.6)
Trial registration not mentioned directly
All (n¼64, 100%) 33 (51.6) 31 (48.4)
2004e2005 15 (45.5) 17 (54.8)
$2006 18 (54.5) 4 (12.9)
Not speciﬁed 0 10 (32.2)
RCTs, randomised controlled trials.
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Trial registration in urologyas the comprehensive and transparent publication of all
trial results in either a register or a journal. This trans-
parency would guarantee public access to research
results. Our study points to some limitations on the road
to this ideal setup. On the one hand, not all trials are
registered yet. Furthermore, some registered trials are
not identiﬁed as such in their publication, so to obtain
access to the additional information provided by the
entry in the register, a separate search is required.
Consequently, a reference to the registration number of
trials should be mandatory in publications. One
consideration, though, is that if journal editors rigor-
ously require trial registration prior to the start of
patient recruitment as a precondition for publication,
only these prospectively registered trials could be
published in the future. Although such a practice
would be consistent with the ICMJE recommendations, it
could lead to the non-publication of non-registered
trials, increasing the proportion of non-published
studies.
CONCLUSIONS
A statement of registration in author instructions
resulted in a higher proportion of registered RCTs.
However, journal editors could still do more by giving
advice about trial registration in their author instruc-
tions and by ensuring that manuscripts include regis-
tration details of trials published in their journal. It is
not, however, only the editors’ responsibility to ensure
trial registration. In fact, the scientists and authors need
to act to ensure trial registration. Researchers and
sponsors should consider trial registration as an ethical
imperative to enhance transparency in research and not
as an obstacle to research.
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